Susquehanna International Group’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Sell |
33,962
-316,074
| -90% | -$3.54M | ﹤0.01% | 4709 |
|
|
2025
Q1 | $3.59M | Buy |
+350,036
| New | +$3.59M | ﹤0.01% | 1571 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6961 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6712 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6743 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6767 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6750 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6511 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6597 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6805 |
|
|
2022
Q4 | – | Sell |
-26,184
| Closed | -$647K | – | 6890 |
|
|
2022
Q3 | $647K | Buy |
26,184
+7,191
| +38% | +$178K | ﹤0.01% | 3154 |
|
|
2022
Q2 | $568K | Buy |
+18,993
| New | +$568K | ﹤0.01% | 3193 |
|
|
2022
Q1 | – | Sell |
-2,672
| Closed | -$69K | – | 6637 |
|
|
2021
Q4 | $69K | Sell |
2,672
-6,498
| -71% | -$168K | ﹤0.01% | 5407 |
|
|
2021
Q3 | $326K | Buy |
9,170
+691
| +8% | +$24.6K | ﹤0.01% | 4208 |
|
|
2021
Q2 | $355K | Sell |
8,479
-405
| -5% | -$17K | ﹤0.01% | 4288 |
|
|
2021
Q1 | $389K | Buy |
8,884
+6,197
| +231% | +$271K | ﹤0.01% | 4106 |
|
|
2020
Q4 | $129K | Buy |
+2,687
| New | +$129K | ﹤0.01% | 4422 |
|
|
2019
Q2 | – | Sell |
-337
| Closed | -$27K | – | 5110 |
|
|
2019
Q1 | $27K | Buy |
+337
| New | +$27K | ﹤0.01% | 2821 |
|
|
2018
Q3 | – | Sell |
-221
| Closed | -$26K | – | 4864 |
|
|
2018
Q2 | $26K | Buy |
+221
| New | +$26K | ﹤0.01% | 3488 |
|
|
2018
Q1 | – | Sell |
-48
| Closed | -$14K | – | 4670 |
|
|
2017
Q4 | $14K | Buy |
+48
| New | +$14K | ﹤0.01% | 3564 |
|
|
2015
Q3 | – | Sell |
-376
| Closed | -$653K | – | 4600 |
|
|
2015
Q2 | $653K | Buy |
+376
| New | +$653K | ﹤0.01% | 3118 |
|